• Latest Posts

EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19

mRNA Stocks Soar with Final Results of BioNTech’s Covid-19 Vaccine

Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise

Lyme Disease Vaccine Gets Pfizer’s Backing in €284M Deal

Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment


Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes

European Project Launches to Tailor Autoimmune Disease Treatments

More News! 9 May 2019

Pfizer Pays up to €700M to Acquire Swiss Biotech Restoring Bone Growth in Achondroplasia

Update: Two-Drug HIV Treatment Effective for up to Three Years

In Depth 1 Oct 2018

Could These Innovative Flu Vaccines Prevent Deaths From Deadly Outbreaks?

Pfizer Offers €374M for German mRNA Flu Vaccine